FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medications and concerns composition for treatment and prevention of hypertension, which includes nebivolol or its pharmaceutically acceptable salt and angiotensin II receptor blocker (ARB).
EFFECT: composition by invention ensures synergetic effect in treatment of hypertension.
8 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING NEBIVOLOL | 2010 |
|
RU2593335C2 |
| COMPOSITIONS CONTAINING NEBIVOLOL | 2005 |
|
RU2441653C2 |
| PHARMACEUTIC COMPOSITION, WHICH CONTAINS HYDROXYLATED NEBIVOLOL | 2006 |
|
RU2433823C2 |
| GLUCURONIDATED NEBIVOLOL METABOLITES | 2006 |
|
RU2413518C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| COFORMULATED DRUG FOR CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THERAPY | 2007 |
|
RU2464014C2 |
| DETERMINING HGH FOR USE IN PREVENTING A SEVERE ADVERSE CARDIOVASCULAR EVENT OR CARDIOVASCULAR DISEASE IN AN INDIVIDUAL | 2015 |
|
RU2740254C2 |
| COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION ADMINISTERED BY INHALATION AND METHODS FOR USING THEM | 2004 |
|
RU2491072C2 |
| USING HYALURONIDASE FOR PREVENTING OR TREATING ARTERIAL HYPERTENSION OR CARDIAC FAILURE | 2009 |
|
RU2508124C2 |
| PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2503668C2 |
